Choose by project and cash need, not by the headline value of a scheme. R&D tax relief can support qualifying expenditure through the corporation-tax system after costs are incurred. An Innovate UK grant is competitively awarded against a defined competition and project. An innovation loan is repayable finance for an eligible SME with a close-to-market innovation and a credible route to repayment. They address different risks and arrive on different timetables.
- OverviewChoose by project and cash need, not by the headline value of a scheme.
- Define one project with a decision at the endDescribe the technical uncertainty, present knowledge, work packages, responsible people, external suppliers, milestones and evidence that will show whether the project succeeded.
- R&D tax relief follows qualifying expenditure and tax rulesFor accounting periods beginning on or after 1 April 2024, the HMRC guidance on the merged R&D expenditure credit and enhanced R&D intensive support describes the main reformed schemes.
- An Innovate UK grant is a competition, not a general entitlementInnovate UK grants are offered through specific opportunities.
- An innovation loan must be repaid from a credible businessInnovate UK describes innovation loans as competitively awarded finance for UK micro, small and medium-sized enterprises.
Choose by project and cash need, not by the headline value of a scheme. R&D tax relief can support qualifying expenditure through the corporation-tax system after costs are incurred. An Innovate UK grant is competitively awarded against a defined competition and project. An innovation loan is repayable finance for an eligible SME with a close-to-market innovation and a credible route to repayment. They address different risks and arrive on different timetables.
For a 12 to 24-month programme, build the technical work plan and monthly cash flow first. Then test each cost against current rules, competition scope, payment profile, evidence burden, control, collaboration, security and repayment. A mixed package may be possible, but the same cost cannot simply be counted twice and every source must be reflected consistently in the accounts and claims.
Define one project with a decision at the end
Describe the technical uncertainty, present knowledge, work packages, responsible people, external suppliers, milestones and evidence that will show whether the project succeeded. Separate research and experimental work from routine product development, customer configuration, sales and production. This definition becomes the common base for comparing finance.
Add a commercial decision at the end of the funded period. The company might proceed to clinical validation, build a pilot line, launch a regulated product, license intellectual property or stop. A funding application that ends with a prototype but no decision route can create an asset the business cannot afford to complete.
The proposed Shoreditch Talk investigation Can London turn quantum research into paying customers? uses this distinction between a technical milestone and commercial evidence. The same discipline applies to any innovation-finance choice.
R&D tax relief follows qualifying expenditure and tax rules
For accounting periods beginning on or after 1 April 2024, the HMRC guidance on the merged R&D expenditure credit and enhanced R&D intensive support describes the main reformed schemes. The merged credit and enhanced support for qualifying loss-making R&D-intensive SMEs use related expenditure concepts but have different calculations and conditions.
Tax relief is not an award for describing a product as innovative. The project must seek an advance in science or technology and address uncertainty that a competent professional could not readily resolve. Qualifying categories, contractor rules, overseas restrictions, PAYE caps and the party entitled to claim require fact-specific analysis.
Cash timing matters. The company incurs expenditure, closes its accounting period, prepares the evidence and submits the claim through its Company Tax Return process. Some companies must notify HMRC in advance of an intended claim. Claims also require an additional information form. The board should not put an expected tax benefit into the cash runway without modelling the filing date, review risk and payment steps.
R&D tax relief usually preserves project control because it is not a competition that selects the company's research agenda. Its weakness as project finance is timing and uncertainty. The company needs enough cash to perform the work before the tax outcome is known.
An Innovate UK grant is a competition, not a general entitlement
Innovate UK grants are offered through specific opportunities. The UKRI Funding Finder sets out each live competition's scope, eligibility, dates, funding rules and assessment process. A strong project can still be ineligible if it falls outside the call, company type, geography, collaboration model or project dates.
The application should explain why public support changes the project, why the technical and commercial plan is credible, and why the work offers wider benefit. Budgets must match the competition's eligible-cost rules. Where collaboration is required or advantageous, the consortium needs agreed work packages, intellectual-property treatment, reporting and a lead organisation.
An award is not cash without conditions. The company must sign the grant agreement, meet reporting and claims requirements and manage changes. Payment may follow evidence of expenditure or milestones rather than precede every cost. A finance team should model working capital between spending and reimbursement and allow for costs that the grant does not cover.
The grant can reduce dilution and provide external technical scrutiny. It can also constrain timing and scope. A company should not delay an urgent customer-led project solely to wait for a competition with an uncertain result.
An innovation loan must be repaid from a credible business
Innovate UK describes innovation loans as competitively awarded finance for UK micro, small and medium-sized enterprises. The live competition terms determine the eligible project, amount, interest, availability, repayment, security and covenants. The current guidance must be read with the specific opportunity.
A loan is appropriate only when the company can connect technical delivery to commercial cash generation and demonstrate the ability to service debt. It avoids equity dilution, but it creates fixed obligations even if customer adoption is slower than planned. The board should model delayed launch, reduced revenue, cost overrun and the effect of covenants on later fundraising.
The 2026 innovation-loan expression of interest describes close-to-market projects with strong commercial potential. That wording should not be stretched to fit early discovery work without a defined commercial path. A grant or equity may be more suitable where the main uncertainty is still fundamental science or where repayment cannot reasonably begin on the proposed schedule.
Compare eligible costs and timing line by line
Build a single cost ledger with employees, externally provided workers, contractors, materials, software, equipment, travel, testing, regulatory work, overheads and commercial activity. For each funding route, mark the eligible proportion, evidence required, claim date and cash date. Do not apply one scheme's definition to another.
Tax rules determine R&D relief costs. Competition documents determine grant and loan costs. Accounting treatment is a separate question. The company's ledger needs project codes and supplier records that allow each figure to be traced to work performed.
Use three cash-flow cases:
- Funding is approved and paid on the planned timetable.
- Approval or payment is delayed by six months.
- The application or claim produces no usable cash during the programme.
If the company cannot complete a safe stopping point in the third case, the project is relying on an uncertain financing event rather than funded execution.
Mixed finance needs an explicit allocation method
A company can use more than one source across a programme, but it must understand the interaction. State aid or subsidy treatment, grant conditions, tax rules and loan covenants can affect which expenditure remains eligible and how support is disclosed. HMRC's Corporate Intangibles Research and Development Manual sets out claim-process requirements for the reformed tax schemes, while each Innovate UK agreement governs its own project.
Create a funding allocation approved by finance and the project lead. It should identify each work package, cost owner and source, and show where company cash or equity covers the balance. Review it when scope, suppliers or timing change.
Angel equity may finance work that grants, loans or tax relief do not. The SEIS and EIS readiness guide explains that investor tax relief and project support are distinct analyses. Do not tell investors that a future grant or tax claim is secured unless it has actually been awarded or accepted.
Evidence should be created during the work
For tax relief, retain the competent professional's account of the advance and uncertainties, the work performed, unsuccessful routes and cost methodology. For a grant, retain the approved application, offer, collaboration agreement, change approvals, timesheets, invoices and milestone evidence. For a loan, add board approvals, forecasts, covenant reporting and repayment monitoring.
Evidence created at the end is usually weaker than contemporaneous records. Add technical decisions to existing product or laboratory workflows rather than asking teams to reconstruct a year of work for a claim. Finance should reconcile the project ledger to statutory accounts and identify where estimates were used.
A practical selection matrix
R&D tax relief is worth testing when the company is carrying out qualifying work, can fund the expenditure and can maintain the required tax evidence. A grant is worth pursuing when a live competition fits the project, the timetable is tolerable and the business accepts the scope and reporting conditions. An innovation loan is worth considering when the company is an eligible SME, the project is close enough to market and repayment remains credible under a downside case.
Use equity or internal cash when speed, flexibility or risk makes those schemes a poor fit. Use staged work when the company cannot yet support the entire programme. The right answer can be a sequence, but each stage should have its own decision, budget and evidence.
Limitations
Tax legislation, HMRC practice and Innovate UK competition terms change. Eligibility depends on the company, accounting period, project, contracts, costs and other support. This article does not calculate relief, promise an award or provide tax, legal, accounting or finance advice. Sources were checked on 13 October 2026. A specialist must review the current rules and the proposed package before the company commits expenditure or signs an agreement.
Reporting by Shoreditch Talk




